IBJNews

BrightPoint stock sinks on lower earnings report

Back to TopCommentsE-mailPrintBookmark and Share

BrightPoint Inc. stock fell as much as 12 percent early Friday morning following disappointing first-quarter earnings that prompted the company to lower its 2012 financial forecast.

Shares rebounded slightly and were fetching $6.36 in late-morning trading, but nevertheless were down 9 percent from their $7 close on Thursday.

Rough conditions in the global wireless industry hurt earnings, the Indianapolis-based logistics provider reported Thursday afternoon after markets closed.

BrightPoint's net income was $3.2 million, or 5 cents per share, down significantly from $8 million, or 11 cents per share, in the year-ago quarter and from $15 million in the fourth quarter of 2011.

Revenue was $1.37 billion, up 23 percent from the same quarter a year ago, but down from the fourth quarter.

“We are reporting solid results in revenue and units handled for the first quarter of 2012," CEO Robert Laikin said in a prepared statement. “However, our customers and vendor partners faced significant competitive and economic pressures in the first quarter, which negatively impacted our profitability.”

BrightPoint handled 29.2 million mobile devices in the quarter. That was a 7-percent increase over the first quarter of 2011, but a 5-percent decrease from the fourth quarter.

BrightPoint said it expects per-share income for the year to range from 57 cents to 63 cents, which would be down from its previous forecast of 66 cents to 72 cents.

BrightPoint said it took $2.4 million in restructuring charges in the quarter, including the anticipated sale of its Reno, Nev., facility, plus severance expenses from downsizing. The company laid off an undisclosed number of people in its Americas division and had “continued consolidation and rationalization” in its Europe, Middle East and Africa and corporate divisions.

The company reported adjusted net income of 16 cents per share, which missed analyst estimates by 2 cents. However, it beat the average revenue estimate of $1.29 billion.

ADVERTISEMENT

  • Broghtpoint
    While shareholders and REGULAR employees suffer, top management was able to increase their siphoning by 11% over 2010. When will the top pull figure out they ain't getting done as leaders and leave? Annual meeting next week and always curious when I see the directors getting paid $250,000! a year just to show up 4 times per year and, as you can see, do nothing to turn this company around. Bitter, oh yeah, since my BP stock has tanked. Good ole boy clubs more concerned aboyt their own parachutte.

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. So, Pence wants the federal government to ignore the 2008 law that allows children from these countries to argue for asylum in front of a judge. How did this guy become governor? And how is that we'll soon be subjected to repeatedly seeing him on TV being taken seriously as a presidential candidate? Am I in Bizzaro-U.S.A.?

  2. "And the most rigorous studies of one-year preschool programs have shown short-term benefits that fade out in a few years or no benefits at all." So we are going down a path that seems to have proven not to work very well. Right intention, wrong approach?

  3. Well for Dunkin Donuts it might say that even a highly popular outlet can't make a poorly sited location work. That little strip has seen near constant churn for years.

  4. Years ago, the Pharmaceutical and Medical Device companies shifted their research investment away from Medical Institutions to focus more on private research centers, primarily because of medical institution inefficiencies in initiating clinical studies and their inability/commitment to enroll the needed number of patients in these studies. The protracted timelines of the medical institutions were prompting significant delays in the availability of new drug and medical device entities for patients and relatedly, higher R and D expenditures to the commercial industry because of these delays. While the above stated IU Health "ratio is about $2.50 in federal funding for every $1 in industry funding", the available funding is REVERSED as commercial R and D (primarily Phase I-IV clinical work)runs $2.50 to $1 for available federal funding ($76.8B to $30.9B in 2011). The above article significatly understated the available R and D funding from industry......see the Pharma and Medical Device industry websites. Clearly, if medical institutions like IU Health wish to attract more commercial studies, they will need to become more competitive with private clinical sites in their ability to be more efficient and in their commitment to meet study enrollment goals on time. Lastly, to the reference to the above Washington Post article headlined “As drug industry’s influence over research grows, so does the potential for bias", lacks some credibility as both FDA and Institutional Institutional Review Boards must approve the high proportion of these studies before studies are started. This means that both study safety and science must be approved by both entities.

  5. ChIeF and all the other critics – better is better no matter what. Get over it; they are doing better despite you ?

ADVERTISEMENT